Brief: Damora Therapeutics Appoints Biotechnology Leader Jennifer Jarrett As President And Chief Executive Officer
23/03/2026 12:11
March 23 (Reuters) - Damora Therapeutics Inc DMRA.O: DAMORA THERAPEUTICS APPOINTS BIOTECHNOLOGY LEADER JENNIFER JARRETT AS PRESIDENT AND CHIEF EXECUTIVE OFFICER; ADDS TWO INDUSTRY VETERANS TO BOARD OF DIRECTORS Source text: ID:nGNX8QW4Bk Further company coverage: DMRA.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Damora Therapeutics
See all newsUS RESEARCH ROUNDUP-Chevron, Exxon Mobil, GoDaddy
U.S. RESEARCH ROUNDUP-Blackstone, Hartford Insurance, Zevra Therapeutics
U.S. RESEARCH ROUNDUP- Cisco, DTE Energy, Marvell Technology
Brief: Damora Therapeutics Reports First Quarter 2026 Financial Results
Brief: Damora Therapeutics: Lori Firmani To Cease Serving As CFO Effective May 1, 2026 - SEC Filing